Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Shionogi Curbing Supplies of Claritin Dry Syrup after Alesion Recalls
March 18, 2021
- Sawai Reaches Settlement over Doping Substance Contamination Lawsuit
March 18, 2021
- Fujifilm Invests 100 Million Yen in Cell Therapy Startup Cuorips
March 17, 2021
- Eisai’s Anti-Tau Antibody Picked for US Prevention Trial for Inherited Alzheimer’s
March 17, 2021
- CureApp Hypertension Therapeutic App Hits PIII Goal, 2021 Submission Eyed
March 17, 2021
- Morimoto Pharma Looking to Partner with Drug Makers, CMOs to Develop Freeze-Dried COVID Vaccines in Japan
March 17, 2021
- Otsuka Grabs Japan Rights to Perception’s Antidepressant
March 17, 2021
- Nippon Shinyaku Taps Global-Savvy Toru Nakai as New President
March 17, 2021
- Takeda Pitches In Production Capacities for J&J’s COVID-19 Vaccine
March 17, 2021
- Quake-Halted Nipro Plant Affecting Supplies of Pfizer, Espha Generics
March 17, 2021
- Alesion Dry Syrup, Generics Pulled from Shelves over Mutagenic Impurities
March 16, 2021
- Novartis, Meiji to End Copromotion for Ultibro, Seebri
March 16, 2021
- Takeda’s Tanigaki to Helm Nihon Pharm upon Full Acquisition
March 16, 2021
- AstraZeneca, Daiichi Sankyo to Wind Up Nexium Copromotion
March 16, 2021
- Takeda Appoints Milano Furuta as New Japan Chief
March 16, 2021
- Relumina Non-Inferior to Leuprorelin in Japan PIII Study for Endometriosis: ASKA
March 16, 2021
- Face-to-Face Promotions Down 16% in January as Pharma Switches to Online Meetings: Intage
March 16, 2021
- Kyowa Kirin Files G-Lasta for Label Expansion
March 15, 2021
- Takeda Seeks Japan Approval for HAE Med Lanadelumab
March 15, 2021
- Daiichi Sankyo Kicks Off AstraZeneca Vaccine Manufacturing in Japan
March 15, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…